Colella Giovanni M. 4

4 · CASTLIGHT HEALTH, INC. · Filed Aug 18, 2017

Form 4

Period: 2017-08-16

DirectorCEO and Co-Founder10% Owner

Transactions

Exercise/Conversion
Class B Common Stock
2017-08-16+19,063→ 97,969 total
Other
Class B Common Stock
2017-08-17−19,063→ 78,906 total
Other
Class B Common Stock
2017-08-17+19,063→ 46,808 total(indirect: By Trust)
Sale
Class B Common Stock
2017-08-17$3.67/sh−8,100$29,705→ 38,708 total(indirect: By Trust)
Exercise/Conversion
Restricted Stock Units
2017-08-16−19,063→ 190,625 total
Exercise: $0.00→ Class B Common Stock (19,063 underlying)

Footnotes (8)

[F1]Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
[F2]Re-registration of shares in the name of the Reporting Person's living trust, effecting only a change in the form of beneficial ownership.
[F3]Reporting Person serves as a co-trustee.
[F4]Represents the aggregate of sales effected on the same day at different prices.
[F5]All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSUs.
[F6]Represents the weighted average sales price per share. The shares sold at prices ranging from $3.50 to $3.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
[F7]Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
[F8]The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.

Documents

1 file